Werner Poewe

Werner Poewe

UNVERIFIED PROFILE

Are you Werner Poewe?   Register this Author

Register author
Werner Poewe

Werner Poewe

Publications by authors named "Werner Poewe"

Are you Werner Poewe?   Register this Author

100Publications

3695Reads

44Profile Views

Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

CNS Drugs 2019 Sep;33(9):905-918

Department of Neurology, Innsbruck Medical University, Anichstraße 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-019-00661-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776563PMC
September 2019

Comment: Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?

Neurology 2019 Jul 31;93(1):25. Epub 2019 May 31.

From the Department of Neurology, Medical University Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007721DOI Listing
July 2019

Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study.

BMC Neurol 2019 Jun 25;19(1):141. Epub 2019 Jun 25.

Department of Neurology, Parkinson Center Nijmegen (ParC) Nijmegen, Donders institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, PO Box 9101, 6500, HB, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-019-1365-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591947PMC
June 2019

Smelling Parkinson's Disease: New Metabolomic Biomarker for PD.

Authors:
Werner Poewe

ACS Cent Sci 2019 Apr 3;5(4):575-576. Epub 2019 Apr 3.

Department of Neurology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acscentsci.9b00319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487465PMC
April 2019

The role of exposure to pesticides in the etiology of Parkinson's disease: a F-DOPA positron emission tomography study.

J Neural Transm (Vienna) 2019 Feb 13;126(2):159-166. Epub 2018 Nov 13.

Department of Nuclear Medicine, Yitzhak Shamir Medical Center, 70300, Zerifin, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-018-1951-8DOI Listing
February 2019

Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.

Parkinsonism Relat Disord 2019 01 7;58:23-27. Epub 2018 Aug 7.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria; Neuroimaging Core Facility, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13538020183033
Publisher Site
http://dx.doi.org/10.1016/j.parkreldis.2018.08.004DOI Listing
January 2019

Safety Profile of Opicapone in the Management of Parkinson's Disease.

J Parkinsons Dis 2019 ;9(4):733-740

Department of Research and Development, BIAL - Portela & Ca SA, S. Mamede do Coronado, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-191593DOI Listing
January 2019

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Parkinsonism Relat Disord 2018 11 8;56:33-40. Epub 2018 Jun 8.

Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Parkinson Centre Nijmegen (ParC) Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.06.015DOI Listing
November 2018

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Mov Disord 2018 10 27;33(10):1528-1539. Epub 2018 Sep 27.

Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC 1436, NS-Park/FCRIN network and NeuroToul COEN Center, INSERM, CHU de Toulouse, Université de Toulouse 3, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27475DOI Listing
October 2018

The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.

Parkinsonism Relat Disord 2018 09 3;54:90-94. Epub 2018 Apr 3.

Department of Neurology, Innsbruck Medical University, Austria; Neuroimaging Core Facility, Medical University Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.04.005DOI Listing
September 2018

Autonomic function testing in Friedreich's ataxia.

J Neurol 2018 Sep 27;265(9):2015-2022. Epub 2018 Jun 27.

Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-018-8946-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132658PMC
September 2018

Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features.

Mov Disord 2018 07;33(6):909-919

Department of Medicine, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27386DOI Listing
July 2018

Autonomic function testing in spinocerebellar ataxia type 2.

Clin Auton Res 2018 06 12;28(3):341-346. Epub 2018 Feb 12.

Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10286-018-0504-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995979PMC
June 2018

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.

Neurodegener Dis Manag 2018 06 10;8(3):161-170. Epub 2018 Apr 10.

Department of Neurology, Medical University of Innsbruck, Innsbruck, A-6060, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt-2017-0046DOI Listing
June 2018

Sensor-based gait analysis in atypical parkinsonian disorders.

Brain Behav 2018 06 7;8(6):e00977. Epub 2018 May 7.

Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University, Erlangen-Nürnberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/brb3.977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991583PMC
June 2018

The reorganization of functional architecture in the early-stages of Parkinson's disease.

Parkinsonism Relat Disord 2018 05 8;50:61-68. Epub 2018 Feb 8.

Department of Neurology, Medical University of Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria; Neuroimaging Research Core Facility, Medical University of Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.02.013DOI Listing
May 2018

Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.

Neurology 2018 05 25;90(21):e1849-e1857. Epub 2018 Apr 25.

From the Instituto de Medicina Molecular (J.J.F.), Faculty of Medicine, University of Lisbon; CNS-Campus Neurológico Sénior (J.J.F.), Torres Vedras, Portugal; University College London (A.J.L.), Reta Lila Weston Institute, UK; Department of Neurology (W.P.), Medical University Innsbruck, Austria; Université de Toulouse (O.R.), CHU de Toulouse, Institut National de la Santé et de la Recherche Médicale, Department of Neurosciences and Clinical Pharmacology, Clinical Investigation Center 1436, and NeuroToul Center of Excellence in Neurodegeneration France; Department of Research and Development (J.-F.R., P.S.-d.-S.), BIAL-Portela & Ca SA, S. Mamede do Coronado, Portugal; Department of Biostatistics (B.K.), Clinipace Worldwide, Eschborn, Germany; and Department of Pharmacology and Therapeutics (P.S.-d.-S.), Faculty of Medicine, University Porto, Portugal.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005557DOI Listing
May 2018

Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.

Parkinsonism Relat Disord 2018 04 7;49:81-87. Epub 2018 Feb 7.

Department of Neurology, Medical University of Innsbruck, Austria; Neuroimaging Research Core Facility, Medical University of Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.02.004DOI Listing
April 2018

MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.

Parkinsonism Relat Disord 2018 01 31;46:47-55. Epub 2017 Oct 31.

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; Neuroimaging Core Facility, Medical University Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.10.020DOI Listing
January 2018

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology 2018 01 13;90(2):74-82. Epub 2017 Dec 13.

From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square Brain Bank (J.H.), UCL Institute of Neurology (N.P.Q.), London, UK; UPS, INSERM, and CHU de Toulouse (O.R.), University de Toulouse; Centre de Référence Maladie Rare contre l'AMS (O.R.), Centre d'Investigation Clinique CIC1436, Départments de Pharmacologie Clinique et de Neurosciences, NeuroToul/COEN Center of Excellence in Neurodegeneration, Toulouse, France; Department of Pathology & Laboratory Medicine (L.M.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Manhasset, NY; The Multiple System Atrophy (MSA) Coalition, Inc. (P. B., J.B., P.F., L.K., C.L., C.R., S.S.), Charlotte, NC; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Medical Affairs (V.A.), Teva Pharmaceuticals, Frazer, PA; Department of Neurology (G.B.), David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles; Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK; Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, Grand Rapids, MI; Center for Neurological Restoration (H.F.), Cleveland Clinic, OH; Defeat MSA (P.F.); MSA Shoe Charity (P.F., C.R.), Saint Clair Shores, MI; Department of Neurology (R.F.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurodegenerative Diseases (T.G.), Hertie Institute of Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.), Tübingen, Germany; Lundbeck LLC (A.H.), Deerfield, IL; German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Munich; Department of Neurology (G.U.H.), Technical University of Munich, Germany; Neurogenomics Division (M.J.H.), The Translational Genomics Research Institute, Phoenix, AZ; Dandrite & Department of Biomedicine (P.H.J.), Aarhus University, Denmark; Quanterix (A.J.), Lexington, MA; Department of Neurology (U.J.K.), Columbia University Medical Center; Department of Neurology (H.K.), New York University School of Medicine, New York; Whitehead Institute for Biomedical Research (V.K.), Cambridge; Ann Romney Center for Neurologic Disease (V.K.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard Stem Cell Institute (V.K.), Cambridge, MA; Department of Neurology (T.K.), University of Bonn; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany; Brain and Mind Centre (W.S.K.), Sydney Medical School, University of Sydney, Australia; Department of Neurology (P.L.), Henry Ford Hospital; Department of Neurology (P.L.), Wayne State University School of Medicine, Detroit, MI; Division of Neurosciences (E.M.), National Institute on Aging/NIH, Bethesda, MD; Centre de Référence Maladie Rare AMS (W.M.), Hôpital Pellegrin, CHU de Bordeaux; Université de Bordeaux (W.M.), Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux; Paris Saclay Institute of Neuroscience (R.M.), CNRS, Gif-sur-Yvette, France; Genentech Inc. (S.O.), South San Francisco; Cedars-Sinai Medical Center (S.P.), Los Angeles, CA; Department of Neurology (D.R.), Vanderbilt University Medical Center, Nashville, TN; MSA NJ (C.R.), Howell, NJ; Prothena Biosciences (D.S.), South San Francisco, CA; Division of Neurology (M.S.), Department of Medicine, The Ottawa Hospital, Canada; Department of Neurology (J.D.S.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Cure MSA Foundation (L.S.), Fremont, CA; Avid Radiopharmaceuticals (A.S.), Philadelphia, PA; Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (S.T.), Graduate School of Medicine, Tokyo University, Tokyo, Japan; and University of Washington (J.Z.), Seattle. W.R.G. is currently affiliated with Janssen Research and Development, Titusville, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772155PMC
January 2018

Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.

Lancet Neurol 2017 11;16(11):898-907

Institute of Neurogenomics, Helmholtz Zentrum München, German Research Centre for Environmental Health, Neuherberg, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Institute of Human Genetics, Technische Universität München, Munich, Germany; Neurologische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(17)30327-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755468PMC
November 2017

Insulin signalling: new target for Parkinson's treatments?

Lancet 2017 10 3;390(10103):1628-1630. Epub 2017 Aug 3.

Department of Neurology, Medical University Innsbruck, Anichstrasse 35, AT-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)32101-3DOI Listing
October 2017

Levodopa and Parkinson Disease-Myths Revisited.

JAMA Neurol 2017 10;74(10):1270

Division of Neurology and the Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, University of Malaya, Kuala Lumpur, Malaysia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2017.2560DOI Listing
October 2017

Parkinson's disease and the quest for preclinical diagnosis: an interview with Professor Werner Poewe.

Authors:
Werner Poewe

Neurodegener Dis Manag 2017 Oct 18;7(5):273-277. Epub 2017 Oct 18.

Medical University Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt-2017-0027DOI Listing
October 2017

Gray matter abnormalities of the dorsal posterior cingulate in sleep walking.

Sleep Med 2017 Aug 29;36:152-155. Epub 2017 May 29.

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sleep.2017.05.007DOI Listing
August 2017

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.

Parkinsonism Relat Disord 2017 Jul 21;40:1-10. Epub 2017 Feb 21.

Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.02.014DOI Listing
July 2017

Very late-onset pure autonomic failure.

Mov Disord 2017 07 24;32(7):1106-1108. Epub 2017 Apr 24.

Department of Neurology - Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200125PMC
July 2017

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.

Expert Rev Neurother 2017 Jul 5;17(7):649-659. Epub 2017 Jun 5.

g Department of Neurology , Innsbruck Medical University , Innsbruck , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2017.1336086DOI Listing
July 2017

Characterization of patients with longstanding idiopathic REM sleep behavior disorder.

Neurology 2017 Jul 14;89(3):242-248. Epub 2017 Jun 14.

From the Neurology Service (A.I., M.S., M.J.M., C.G., A.F.-A., E.T., J.S.) and Nuclear Medicine Service (F.L.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Spain; and Department of Neurology (A.S., P.M., H.S., W.P., B.H.), Medical University Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004121DOI Listing
July 2017

IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome.

Parkinsonism Relat Disord 2017 05 6;38:102-103. Epub 2017 Mar 6.

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.03.002DOI Listing
May 2017

Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.

Mov Disord 2017 04 2;32(4):619-623. Epub 2017 Feb 2.

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26932DOI Listing
April 2017

Brain structural profile of multiple system atrophy patients with cognitive impairment.

J Neural Transm (Vienna) 2017 03 24;124(3):293-302. Epub 2016 Oct 24.

Parkinson Disease and Movement Disorders Unit, IRCCS San Camillo Hospital Foundation, via Alberoni, 70, 30126, Venice-Lido, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00702-016-1636-0
Publisher Site
http://dx.doi.org/10.1007/s00702-016-1636-0DOI Listing
March 2017

Parkinson disease.

Nat Rev Dis Primers 2017 Mar 23;3:17013. Epub 2017 Mar 23.

Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.13DOI Listing
March 2017

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

JAMA Neurol 2017 Feb;74(2):197-206

Department of Research and Development, BIAL-Portela & Ca SA, Sao Mamede do Coronado, Portugal8Department of Pharmacology and Therapeutics, University Porto, Porto, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.4703DOI Listing
February 2017

1.5 Versus 3 tesla magnetic resonance planimetry in neurodegenerative parkinsonism.

Mov Disord 2016 12 25;31(12):1925-1927. Epub 2016 Oct 25.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26823DOI Listing
December 2016

Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia.

Am J Hum Genet 2016 Dec 10;99(6):1377-1387. Epub 2016 Nov 10.

Institut für Neurogenomik, Helmholtz Zentrum München, 85764 Munich, Germany; Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany; Munich Cluster for Systems Neurology, SyNergy, 81377 Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2016.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142117PMC
December 2016

Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's.

Parkinsonism Relat Disord 2016 12 22;33 Suppl 1:S9-S12. Epub 2016 Dec 22.

Medical University Innsbruck, Department of Neurology, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2016.12.004DOI Listing
December 2016

Pharmacogenetics of Parkinson's Disease in Clinical Practice.

Mov Disord Clin Pract 2017 Mar-Apr;4(2):173-180. Epub 2016 Nov 1.

Department of Neurology Medical University Innsbruck Innsbruck Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174439PMC
November 2016

Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy.

Mov Disord Clin Pract 2017 May-Jun;4(3):389-396. Epub 2016 Nov 2.

Department of Neurology Medical University of Innsbruck Innsbruck Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174450PMC
November 2016

Minimally clinically important decline in the parkinsonian variant of multiple system atrophy.

Mov Disord 2016 10;31(10):1577-1581

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26743DOI Listing
October 2016

Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controls.

Parkinsonism Relat Disord 2016 10 25;31:119-123. Epub 2016 Jul 25.

Klinik und Poliklinik für Neurologie, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2016.07.013DOI Listing
October 2016

Reply to letter: Nonmotor symptoms in subjects without evidence of dopaminergic deficits.

Mov Disord 2016 10;31(10):1588-1589

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26757DOI Listing
October 2016

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.

Neurotherapeutics 2016 10;13(4):871-879

Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-016-0447-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081120PMC
October 2016

Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?

Neurology 2016 07 3;87(1):36-40. Epub 2016 Jun 3.

From the Departments of Neurology (B. Heim, A.D., A.H., A.S., L.Z., M.-T.P., E.B., M.D., K.S., W.P., B. Högl) and Psychology (M.-T.P.), Medical University Innsbruck, Austria; and Department of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies (A.D.), University of London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002803DOI Listing
July 2016

Severe dysphagia, myalgia, and rash in a 55-year-old man.

J Dtsch Dermatol Ges 2016 Apr 28;14(4):438-41. Epub 2016 Mar 28.

Department of Dermatology and Venereology, Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ddg.12863
Publisher Site
http://dx.doi.org/10.1111/ddg.12863DOI Listing
April 2016